Literature DB >> 25850587

Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence.

Zeynep Sıklar1, Merih Berberoğlu2, Emine Çamtosun2, Pınar Kocaay2.   

Abstract

STUDY
OBJECTIVE: Polycystic ovary syndrome (PCOS) is a disorder without definite consensus on its diagnosis and management during adolescence. According to Amsterdam-2012 consensus, as physiological characteristics of adolescence may overlap with PCOS signs, it has been indicated that all Rotterdam criteria should be met. In this present study, characteristics of adolescents with different phenotypes who were diagnosed with PCOS were evaluated; and presence of differences for metabolic risk factors between phenotypes were investigated.
DESIGN: The study was performed on adolescent females. According to phenotypic application models, individuals with all Rotterdam diagnostic criteria [hyperandrogenism (HA), polycystic ovarian morphology (PCOM), and chronic anovulation (CA) on the ultrasonography] were in Group 1 (n = 26); with HA and CA were in Group 2 (n = 10); with HA and PCOM were in Group 3 (n = 7); and with CA and PCOM were in Group 4 (n = 10).
RESULTS: The most common application complaint (87%) among 53 cases enrolled in the study was menstrual irregularities, and 57% of cases were not obese. When PCOS was evaluated according to phenotypes, it was realized that cases that meet all 3 diagnostic Rotterdam criteria according to the current recommendation in adolescents. (Group 1) was the most common phenotype. Hyperandrogenism was associated with more metabolic abnormalities.
CONCLUSION: The close monitoring of adolescents, who have 2 diagnostic criteria is advisable among PCOS phenotypes. Potentially Groups 2 and 3 which have hyperandrogenism, in particular should warrant closer follow-up although they do not meet current diagnostic criteria for adolescents.
Copyright © 2015 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescents; Diagnosis; Polycystic ovary syndrome

Mesh:

Year:  2014        PMID: 25850587     DOI: 10.1016/j.jpag.2014.05.006

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  5 in total

1.  Role of CPXM1 in Impaired Glucose Metabolism and Ovarian Dysfunction in Polycystic Ovary Syndrome.

Authors:  Sadaf Pervaz; Amin Ullah; Enoch Appiah Adu-Gyamfi; Jones Lamptey; Sanjay Kumar Sah; Mei-Jiao Wang; Ying-Xiong Wang
Journal:  Reprod Sci       Date:  2022-06-13       Impact factor: 3.060

Review 2.  Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome.

Authors:  Kristen P Hamilton; Rena Zelig; Anna R Parker; Amina Haggag
Journal:  Curr Dev Nutr       Date:  2019-10-03

Review 3.  Poly Cystic Ovarian Syndrome: An Updated Overview.

Authors:  Samer El Hayek; Lynn Bitar; Layal H Hamdar; Fadi G Mirza; Georges Daoud
Journal:  Front Physiol       Date:  2016-04-05       Impact factor: 4.566

4.  Effect of metformin on insulin levels, blood sugar, and body mass index in polycystic ovarian syndrome cases.

Authors:  Nidhi Sharma; Yogita Lugani; Avneet Kaur; Vineet Kaur Ahuja
Journal:  J Family Med Prim Care       Date:  2019-08-28

Review 5.  Polycystic Ovary Syndrome in Adolescence.

Authors:  Rebecca Deans
Journal:  Med Sci (Basel)       Date:  2019-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.